Continuous Glucose Monitoring After Kidney Transplant
Part of Hormones & metabolism clinical trials.
This study tests a small sensor called a continuous glucose monitor (CGM) that tracks your blood sugar after kidney transplant. It helps doctors see how your body handles sugar during recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a kidney transplant.
- You are 18 years or older.
- You can use a small monitor on your skin for the first 10 days after surgery.
- You have no allergy to the sticky pads used with continuous glucose monitors.
- You have not had a combined kidney-liver or kidney-pancreas transplant.
- Your new kidney is still working well 48 hours after transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether using a continuous glucose monitor (a sensor that tracks sugar throughout the day) is helpful and practical for people with a recent kidney transplant and type 2 diabetes on insulin. You may need to wear the sensor continuously and still do finger-stick glucose checks for safety.
This study tests whether a continuous glucose monitor (CGM) can help manage blood sugar levels in patients who have just received a liver transplant and have high blood sugar in the hospital.
This study tests whether using a real-time continuous glucose monitor (a device that tracks your blood sugar continuously) helps improve blood sugar control in people with type 2 diabetes who also have chronic kidney disease (stages 3 and 4). If you qualify, you may get better insight into your glucose patterns, which could help you manage your diabetes more effectively.
This study uses a continuous glucose monitor (CGM) to watch for early signs that a transplanted pancreatic islet graft may be losing function. The goal is to catch problems sooner and help keep the transplant working well.
This study tests whether a wearable glucose monitor (Dexcom G7) works well in patients in intensive care after major abdominal surgery or organ transplant who need insulin therapy. The monitor measures blood sugar continuously to help doctors manage insulin doses more safely.
This study looks at how people with diabetes feel about using a continuous glucose monitor (CGM) and their blood sugar readings. It aims to learn what works best for patients and healthcare providers to improve diabetes care.
Hear when a new Hyperglycaemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.